HealthAssure
HealthAssureGood Life
LOINCActiveObservation

LOINC Code 76545-3: Breast cancer 10-year risk of distant recurrence classification Prosigna Ql [Interp]

76545-3 is a LOINC code used to identify Breast cancer 10-year risk of distant recurrence classification Prosigna Ql [Interp] in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Breast cancer 10Y risk of distant recurrence classification. It is commonly used with the system or sample type ^Patient.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Breast cancer 10Y risk of distant recurrence classification. It is commonly used with the system or sample type ^Patient.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: ACTIVE
  • Order vs observation: Observation
  • Method: Prosigna

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

Breast cancer 10-year risk of distant recurrence classification [Interpretation] Qualitative by Prosigna
Breast cancer 10Y risk of distant recurrence classification
The risk classification is an ordinal risk category (low, intermediate, high) that indicates a patient's risk of recurrence of breast cancer at 10 years. The classification is based on the 10-year risk of distant recurrence score and lymph node status. Low risk is associated with a 3% chance (confidence interval 2-6%), intermediate risk is associated with a 10% chance (confidence interval 7-14%), and high risk with a 16% chance (confidence interval 11-22%) of distant breast cancer recurrence at 10 years, respectively. [PMID24347518] This term was created for the Prosigna™ Breast Cancer Prognostic Gene Signature assay, which is intended for use in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), hormone receptor-positive (HR+) breast cancer who have undergone surgery and are to be treated with adjuvant endocrine therapy alone.
breast cancer; Brst ca 10Y risk dist recur class; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Molecular pathology; MOLPATH; Ordinal; PAM50; Point in time; Prosigna; Psoriasis Care Satisfaction questionnaire; Ql; Qual; Qualitative; Random; Screen

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Breast cancer 10-year risk of distant recurrence classification Prosigna Ql [Interp]Breast cancer 10-year risk of distant recurrence classification [Interpretation] Qualitative by ProsignaBrst ca 10Y dist recur class ProsignaBreast cancer 10Y risk of distant recurrence classificationMOLPATHBreast cancer 10-year risk of distant recurrence classificationImp

Frequently asked questions

Code details

Code76545-3
SystemLOINC
Display nameBreast cancer 10-year risk of distant recurrence classification Prosigna Ql [Interp]
DescriptionBreast cancer 10Y risk of distant recurrence classification
Short nameBrst ca 10Y dist recur class Prosigna
ComponentBreast cancer 10Y risk of distant recurrence classification
PropertyImp
TimingPt
System (specimen)^Patient
ScaleOrd
MethodProsigna
ClassMOLPATH
StatusACTIVE
Order/ObservationObservation

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.52
Last changed2.73

Consumer names

Breast cancer 10-year risk of distant recurrence classification

Part names

Breast cancer 10Y risk of distant recurrence classificationImpPt^PatientOrdProsignaBreast cancer 10-year risk of distant recurrence classificationImpression/interpretation of studyPoint in time (spot)Psoriasis Care Satisfaction questionnaire

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.